Good practice guidelines for laboratory investigation of hemoglobinopathies

Laboratory Hematology

Volumn 9, Issue 4, 2003, Pages 237-245

  Lafferty, John D ^a,b   Waye, John S ^a,b   Chui, David H K ^a,b   Crawford, Linda ^c   Raby, Anne ^c   Richardson, Harold ^c  

^a HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Quality Management Program   (Canada)

Author keywords

Hb A2 level; Hb H inclusion bodies; Hemoglobinopathy; Sickle cell anemia; Thalassemia

Indexed keywords

DNA; HEMOGLOBIN; HEMOGLOBIN VARIANT;

ADOLESCENT; ADULT; ALGORITHM; ALPHA THALASSEMIA; CANADA; CELL VOLUME; CHILD; DIAGNOSTIC ERROR; DNA DETERMINATION; FEMALE; GENOTYPE; GOOD LABORATORY PRACTICE; HEALTH SURVEY; HEMOGLOBIN ANALYSIS; HEMOGLOBIN DETERMINATION; HEMOGLOBINOPATHY; HETEROZYGOTE DETECTION; HUMAN; INFANT; LABORATORY DIAGNOSIS; LABORATORY TEST; MALE; MEDICAL EXPERT; PHYSICIAN; PRACTICE GUIDELINE; PROCESSING; REFERENCE VALUE; REVIEW;

ALGORITHMS; ERYTHROCYTE INDICES; HEMOGLOBINOPATHIES; HEMOGLOBINS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; REFERENCE STANDARDS;

EID: 0348133624     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Lafferty J, Crawford L, Richardson H, Waye J, Chui DH. Laboratory screening for hemoglobinopathies in the province of Ontario: proficiency and patterns of practice. Paper presented at: 42nd Annual Meeting of the American Society of Hematology; December 1-5, 2000; San Francisco. Abstract 3764.
2. Committee comments: Survey H-0004-PP hemoglobinopathy patterns of practice. In: Hematology General Binder. Vol 3. Sect 2.2, 209-215. Toronto, ON: Quality Management Program-Laboratory Services; 2000.
3. Statistics Canada. Population by ethnic origin: census 1996. Available at: www.statcan.ca/english/Pgdb/demo28d.htm. Accessed May 2001.
4. Chui DHK, Waye JS. Hydrops fetalis caused by α-thalassemia: an emerging health care problem. Blood. 1998;91:2213-2222.
5. Olivieri N. The β-thalassemias. N Engl J Med. 1999;341:99-109.
6. Weatherall DJ, Clegg JB. Genetic disorders of hemoglobin. Semin Hematol. 1999;36(suppl 7):24-37.
7. Brozovic M, Henthorn J. Investigation of abnormal hemoglobins and thalassemia. In: Dacie JV, Lewis SM, eds. Practical Haematology. Edinburgh: Churchill Livingstone; 1995:249-286.
8. Modell M, Modell B. Genetic screening of ethnic minorities. Br Med J. 1990;300:1702-1704.
9. The laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998;101:783-792.
10. Lafferty J. The laboratory diagnosis of α thalassemia. Can J Med Lab Sci. 1998;60:183-189.
11. Lafferty JD, Crowther MA, Ali MA, Levine M. The evaluation of various mathematical RBC indices and their efficacy in discriminating between thalassemic and non-thalassemic microcytosis. Am J Clin Pathol. 1996;106:201-205.
12. Kiss TL, Ali MAM, Levine M, Lafferty JD. An algorithm to aid in the investigation of thalassemia trait in multicultural populations. Arch Pathol Lab Med. 2000;124:1320-1323.
13. Dumars KW, Boehm C, Eckman JR, et al. Practical guide to the diagnosis of thalassemia. Am J Med Genet. 1996;62:29-37.
14. Skogerboe KJ, West SF, Smith C, et al. Screening for α-thalassemia. Arch Pathol Lab Med. 1992;116:1012-1018.
15. Huisman THJ, Carver MFH, Efremov GF. Methodology for detection and characterization. In: A Syllabus of Human Hemoglobin Variants. Augusta, GA: The Sickle Cell Anemia Foundation; 1996:2-3.
16. Nagel RL. Disorders of hemoglobin function and stability. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge, UK: Cambridge University Press; 2001:1155-1194.
17. 2 reference preparation. Br J Haematol. 1978;38:573-578.
18. Perkins S. Disorders of hemoglobin synthesis. In: Kjeldsberg CR, ed. Practical Diagnosis of Hematologic Disorders. Chicago: ASCP Press; 2000:145-169.
19. 2 in blood samples that contain sickle hemoglobin. Ann Clin Lab Sci. 2000;30:191-194.
20. Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of Hb H disease in Chinese patients. N Engl J Med. 2000;343:544-550.
21. Huisman THJ, Carver MFH, Efremov GF. Hemoglobins with elongated chains. In: A Syllabus of Human Hemoglobin Variants. Augusta, GA: The Sickle Cell Anemia Foundation; 1996:359-367.
22. Huisman THJ, Carver MFH, Efremov GF. Hybrid hemoglobins. In: A Syllabus of Human Hemoglobin Variants. Augusta, GA: The Sickle Cell Anemia Foundation; 1996:383-388.
23. SEA) deletion and clinical diagnosis for α-thal-1 trait. Ann N Y Acad Sci. 1998; 850:429-431.
24. Riou J, Godart C, Hertrel D, et al. Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants. Clin Chem. 1997;43:34-39.
25. Campbell M, Henthorn J, Davies S. Evaluation of cation-exchange HPLC compared with isoelectric focusing for neonatal hemoglobinopathy screening. Clin Chem. 1999;45:969-975.
26. Lafferty J. Discussion specimen HG-05. In: Participant Summary Hemoglobinopathy Survey Set HB-B. Northfield, IL: College of American Pathologists; 1999:3-7.
27. Hb F quantitation and Hb A2 quantitation for specimens HG-04, HG-05, HG-06. In: Participant Summary Hemoglobinopathy Survey Set HG-B. Northfield, IL: College of American Pathologists; 2003:4.
28. Kroft S. Discussion specimen HG-05. In: Participant Summary Hemoglobinopathy Survey Set HB-B. Northfield, IL: College of American Pathologists; 2000:3-4.
29. Lafferty J. Committee comments: survey H-9809-Y. In: Hematology General Binder. Vol 3. Sect 2.2, 136-138. Toronto, ON: Quality Management Program-Laboratory Services; 1998.
30. Lafferty J. Good practice guidelines for the laboratory investigation of hemoglobinopathies. In: Hematology General Binder. Vol 3. Sect 1.2.1, 13-29. Toronto, ON: Quality Management Program-Laboratory Services; 2001.
31. Lafferty J, Ali M, Carstairs K, Crawford L. Proficiency testing of hemoglobinopathy techniques in Ontario laboratories. Am J Clin Pathol. 1997;107:567-575.
32. Lafferty J, Ali M. Carstairs K, Crawford L. The effect of carbon tetrachloride on the detection of hemoglobin H using various commercially available electrophoresis products [letter]. Am J Clin Pathol. 1998;109:651-652.
33. 1c quantitation kit on the Bio-Rad Variant II automated hemoglobin analyzer. Arch Pathol Lab Med. 2002;126:1494-1500.
34. Lafferty J, Crowther M, Waye J, Chui D. A reliable screening test to identify adult carriers of the (- -SEA) α0-thalassemia deletion. Am J Clin Pathol. 2000;114:927-931.
35. Bergstrome J, Poon A. Evaluation of a single-tube multiplex polymerase chain reaction screen for detection of common alpha-thalassemia genotypes in a clinical laboratory. Am J Clin Pathol. 2002;118:18-24.